(Q33985259)

30 July 2017

1 reference

title

Levodopa therapy and the risk of malignant melanoma (English)

1 reference

30 July 2017

1 reference

J F Siple

1

1 reference

30 July 2017

D C Schneider

series ordinal

2

1 reference

30 July 2017

W A Wanlass

series ordinal

3

1 reference

30 July 2017

B K Rosenblatt

series ordinal

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

Annals of Pharmacotherapy

30 July 2017

1 reference

30 July 2017

34

1 reference

30 July 2017

3

1 reference

30 July 2017

382-385

1 reference

Low cancer rates among patients with Parkinson's disease

30 July 2017

1 reference

Levodopa therapy and malignant melanoma

21 January 2018

1 reference

Accelerated growth of malignant melanoma by levodopa in Parkinson's disease and role of the pineal gland

21 January 2018

1 reference

Stimulation of Human-Growth-Hormone Secretion by L-Dopa

21 January 2018

1 reference

Levodopa and melanoma: three cases and review of literature

21 January 2018

1 reference

Parkinson's disease, melanoma, and levodopa

21 January 2018

1 reference

Lid melanoma and parkinsonism

21 January 2018

1 reference

Levodopa, melanoma, and Parkinson's disease

21 January 2018

1 reference

L-Dopa methyl ester as a new antitumour agent

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.19150

1 reference

30 July 2017

1 reference